Skip to content
The Nexus
DossierENTITY

lupus

Coverage of lupus in the Nexus archive.

Earliest in view: May 17 · 11:00 UTCMost recent: Jul 1 · 20:18 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 1 · 20:18 UTCGEORGIA RECORDER
    New state law expected to increase patient access to Georgia’s medical cannabis program

    A new Georgia law, the 'Putting Georgia’s Patients First Act,' removes barriers to medical cannabis access by renaming the program, allowing higher THC limits, expanding qualifying conditions, and adjusting dispensary location rules. The law aims to increase patient enrollment and align Georgia’s program with other states.

  • HEALTHJun 11 · 23:31 UTCBBC HEALTH
    'I've never been this good' – revolutionary immune reset puts lupus in remission

    A revolutionary immune reset treatment has put lupus into remission, with trial patients no longer needing medication to manage their condition.

  • HEALTHJun 11 · 23:01 UTCTHE GUARDIAN WORLD
    Lupus patients in England in remission after pioneering NHS trial of GM therapy

    Five lupus patients in England are in remission after participating in an NHS trial of CAR T-cell therapy, which genetically modifies their T-cells to target and destroy the disease. Doctors describe this as a medical breakthrough that could offer a cure for chronic autoimmune diseases.

  • HEALTHJun 5 · 17:52 UTCMEDPAGE TODAY
    Novel Lupus Drugs Continue to Shine in Extended Early Data

    Two investigational lupus drugs demonstrated continued positive results in follow-on studies after showing encouraging primary phase II outcomes. The Toll-like receptor (TLR) inhibitor enpatoran maintained efficacy without diminution in extended data.

  • HEALTHMay 17 · 11:00 UTCARS TECHNICA
    A revolutionary cancer treatment could transform autoimmune disease

    Jan Janisch-Hanzlik, a 49-year-old multiple sclerosis patient, participated in a CAR T cell therapy trial at the University of Nebraska Medical Center, which aims to transform autoimmune disease treatment by reprogramming immune cells. The therapy, originally designed for cancer, is being tested in hundreds of clinical trials for conditions like lupus and Graves' disease. If successful, it could reset the body's defenses to a pre-disease state.

lupus · Dossier · The Nexus